{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:28:40Z","timestamp":1787956120807,"version":"build-2784847793"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T00:00:00Z","timestamp":1611360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","award":["GRS 1114\/A\/15"],"award-info":[{"award-number":["GRS 1114\/A\/15"]}],"id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11033-021-06150-1","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T20:02:47Z","timestamp":1611432167000},"page":"1601-1606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["sST2 and Galectin-3 genotyping in patients with persistent atrial fibrillation"],"prefix":"10.1007","volume":"48","author":[{"given":"Ruth","family":"Saez-Maleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Merino-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gundin-Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Salgado-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"AlKassam-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pascual-Tejerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martin-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garcia-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1451-1445","authenticated-orcid":false,"given":"Jose-Angel","family":"Perez-Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"issue":"5","key":"6150_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1136\/hrt.2008.155812","volume":"96","author":"RJ Schilling","year":"2010","unstructured":"Schilling RJ (2010) Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs. Heart 96(5):333\u2013338. https:\/\/doi.org\/10.1136\/hrt.2008.155812","journal-title":"Heart"},{"key":"6150_CR2","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.bbadis.2012.12.014","volume":"12","author":"HK Gaggin","year":"1832","unstructured":"Gaggin HK, Januzzi JL Jr (1832) (2013) Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 12:2442\u20132450. https:\/\/doi.org\/10.1016\/j.bbadis.2012.12.014","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"6150_CR3","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jacc.2006.03.061","volume":"48","author":"RR van Kimmenade","year":"2006","unstructured":"van Kimmenade RR, Januzzi JL Jr, Ellinor PT, Sharma UC, Bakker JA, Low AF, Martinez A, Crijns HJ, MacRae CA, Menheere PP, Pinto YM (2006) Utility of amino-terminal pro-brain natriuretic peptide, galectin-3, and apelin for the evaluation of patients with acute heart failure. J Am Coll Cardiol 48(6):1217\u20131224. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.061","journal-title":"J Am Coll Cardiol"},{"key":"6150_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ahj.2017.07.001","volume":"192","author":"OE Fashanu","year":"2017","unstructured":"Fashanu OE, Norby FL, Aguilar D, Ballantyne CM, Hoogeveen RC, Chen LY, Soliman EZ, Alonso A, Folsom AR (2017) Galectin-3 and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 192:19\u201325. https:\/\/doi.org\/10.1016\/j.ahj.2017.07.001","journal-title":"Am Heart J"},{"issue":"6","key":"6150_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.18565\/cardio.2016.6.17-22","volume":"56","author":"A Va","year":"2016","unstructured":"Va A, Zaslavskaya EL, Soboleva AV, Baranova EI, Listopad OV, Nifontov SE, Nrady AO, Shlyakhto EV (2016) Galectin-3 in patients with paroxysmal and persistent atrial fibrillation and metabolic syndrome. Kardiologiia 56(6):41\u201345. https:\/\/doi.org\/10.18565\/cardio.2016.6.17-22","journal-title":"Kardiologiia"},{"issue":"6","key":"6150_CR6","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/jce.12637","volume":"26","author":"MU Yalcin","year":"2015","unstructured":"Yalcin MU, Gurses KM, Kocyigit D, Canpinar H, Canpolat U, Evranos B, Yorgun H, Sahiner ML, Kaya EB, Hazirolan T, Tokgozoglu L, Oto MA, Ozer N, Guc D, Aytemir K (2015) The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling. J Cardiovasc Electrophysiol 26(6):635\u2013640. https:\/\/doi.org\/10.1111\/jce.12637","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"10","key":"6150_CR7","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1093\/europace\/euv045","volume":"17","author":"XY Wu","year":"2015","unstructured":"Wu XY, Li SN, Wen SN, Nie JG, Deng WN, Bai R, Liu N, Tang RB, Zhang T, Du X, Dong JZ, Ma CS (2015) Plasma galectin-3 predicts clinical outcomes after catheter ablation in persistent atrial fibrillation patients without structural heart disease. Europace 17(10):1541\u20131547. https:\/\/doi.org\/10.1093\/europace\/euv045","journal-title":"Europace"},{"issue":"6","key":"6150_CR8","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1172\/JCI30634","volume":"117","author":"S Sanada","year":"2007","unstructured":"Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie AN, Lee RT (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117(6):1538\u20131549. https:\/\/doi.org\/10.1172\/JCI30634","journal-title":"J Clin Invest"},{"issue":"22","key":"6150_CR9","doi-asserted-by":"publisher","first-page":"e1054","DOI":"10.1161\/CIR.0000000000000490","volume":"135","author":"SL Chow","year":"2017","unstructured":"Chow SL, Maisel AS, Anand I, Bozkurt B, de Boer RA, Felker GM, Fonarow GC, Greenberg B, Januzzi JL Jr, Kiernan MS, Liu PP, Wang TJ, Yancy CW, Zile MR (2017) Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the american heart association. Circulation 135(22):e1054\u2013e1091. https:\/\/doi.org\/10.1161\/CIR.0000000000000490","journal-title":"Circulation"},{"issue":"1","key":"6150_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11897-010-0005-9","volume":"7","author":"RV Shah","year":"2010","unstructured":"Shah RV, Januzzi JL Jr (2010) ST2: a novel remodeling biomarker in acute and chronic heart failure. Curr Heart Fail Rep 7(1):9\u201314. https:\/\/doi.org\/10.1007\/s11897-010-0005-9","journal-title":"Curr Heart Fail Rep"},{"key":"6150_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cca.2018.02.005","volume":"480","author":"X Ma","year":"2018","unstructured":"Ma X, Yuan H, Luan HX, Shi YL, Zeng XL, Wang Y (2018) Elevated soluble ST2 concentration may involve in the progression of atrial fibrillation. Clin Chim Acta 480:138\u2013142. https:\/\/doi.org\/10.1016\/j.cca.2018.02.005","journal-title":"Clin Chim Acta"},{"issue":"10","key":"6150_CR12","doi-asserted-by":"publisher","first-page":"920","DOI":"10.4070\/kcj.2018.0047","volume":"48","author":"S Okar","year":"2018","unstructured":"Okar S, Kaypakli O, Sahin DY, Koc M (2018) Fibrosis marker soluble ST2 predicts atrial fibrillation recurrence after cryoballoon catheter ablation of nonvalvular paroxysmal atrial fibrillation. Korean Circ J 48(10):920\u2013929. https:\/\/doi.org\/10.4070\/kcj.2018.0047","journal-title":"Korean Circ J"},{"issue":"10","key":"6150_CR13","doi-asserted-by":"publisher","first-page":"e47385","DOI":"10.1371\/journal.pone.0047385","volume":"7","author":"RA de Boer","year":"2012","unstructured":"de Boer RA, Verweij N, van Veldhuisen DJ, Westra HJ, Bakker SJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Franke L, Mateo Leach I, van der Harst P (2012) A genome-wide association study of circulating galectin-3. PLoS One 7(10):e47385. https:\/\/doi.org\/10.1371\/journal.pone.0047385","journal-title":"PLoS One"},{"issue":"10","key":"6150_CR14","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1172\/JCI67119","volume":"123","author":"JE Ho","year":"2013","unstructured":"Ho JE, Chen WY, Chen MH, Larson MG, McCabe EL, Cheng S, Ghorbani A, Coglianese E, Emilsson V, Johnson AD, Walter S, Franceschini N, O\u2019Donnell CJ, Dehghan A, Lu C, Levy D, Newton-Cheh C, Lin H, Felix JF, Schreiter ER, Vasan RS, Januzzi JL, Lee RT, Wang TJ (2013) Common genetic variation at the IL1RL1 locus regulates IL-33\/ST2 signaling. J Clin Invest 123(10):4208\u20134218. https:\/\/doi.org\/10.1172\/JCI67119","journal-title":"J Clin Invest"},{"issue":"1","key":"6150_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/abbi.1997.0447","volume":"349","author":"MM Kadrofske","year":"1998","unstructured":"Kadrofske MM, Openo KP, Wang JL (1998) The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch Biochem Biophys 349(1):7\u201320. https:\/\/doi.org\/10.1006\/abbi.1997.0447","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"6150_CR16","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s11033-018-4384-4","volume":"45","author":"A Djordjevic","year":"2018","unstructured":"Djordjevic A, Dekleva M, Zivkovic M, Stankovic A, Markovic Nikolic N, Alavantic D, Djuric T (2018) Left ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective study. Mol Biol Rep 45(6):2227\u20132236. https:\/\/doi.org\/10.1007\/s11033-018-4384-4","journal-title":"Mol Biol Rep"},{"issue":"6","key":"6150_CR17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1002\/jcla.21996","volume":"30","author":"A Djordjevic","year":"2016","unstructured":"Djordjevic A, Zivkovic M, Stankovic A, Zivotic I, Koncar I, Davidovic L, Alavantic D, Djuric T (2016) Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study. J Clin Lab Anal 30(6):1150\u20131157. https:\/\/doi.org\/10.1002\/jcla.21996","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"6150_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1006\/geno.1999.5767","volume":"57","author":"M Dale","year":"1999","unstructured":"Dale M, Nicklin MJ (1999) Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1\/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics 57(1):177\u2013179. https:\/\/doi.org\/10.1006\/geno.1999.5767","journal-title":"Genomics"},{"issue":"4","key":"6150_CR19","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/ng.102","volume":"40","author":"KA Hunt","year":"2008","unstructured":"Hunt KA, Zhernakova A, Turner G, Heap GA, Franke L, Bruinenberg M, Romanos J, Dinesen LC, Ryan AW, Panesar D, Gwilliam R, Takeuchi F, McLaren WM, Holmes GK, Howdle PD, Walters JR, Sanders DS, Playford RJ, Trynka G, Mulder CJ, Mearin ML, Verbeek WH, Trimble V, Stevens FM, O\u2019Morain C, Kennedy NP, Kelleher D, Pennington DJ, Strachan DP, McArdle WL, Mein CA, Wapenaar MC, Deloukas P, McGinnis R, McManus R, Wijmenga C, van Heel DA (2008) Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 40(4):395\u2013402. https:\/\/doi.org\/10.1038\/ng.102","journal-title":"Nat Genet"},{"issue":"26","key":"6150_CR20","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1056\/NEJMoa0807917","volume":"359","author":"DJ Smyth","year":"2008","unstructured":"Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, Howson JM, Stevens H, McManus R, Wijmenga C, Heap GA, Dubois PC, Clayton DG, Hunt KA, van Heel DA, Todd JA (2008) Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 359(26):2767\u20132777. https:\/\/doi.org\/10.1056\/NEJMoa0807917","journal-title":"N Engl J Med"},{"key":"6150_CR21","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.ajem.2020.05.051","volume":"39","author":"A Merino-Merino","year":"2021","unstructured":"Merino-Merino A, Saez-Maleta R, Salgado-Aranda R, AlKassam-Martinez D, Pascual-Tejerina V, Martin-Gonzalez J, Garcia-Fernandez J, Perez-Rivera JA (2021) When should we measure biomarkers in patients with atrial fibrillation to predict recurrences? Am J Emerg Med 39:248\u2013249. https:\/\/doi.org\/10.1016\/j.ajem.2020.05.051","journal-title":"Am J Emerg Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06150-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-021-06150-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06150-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T16:12:23Z","timestamp":1614701543000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-021-06150-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["6150"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06150-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]},"assertion":[{"value":"26 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of our center (Reference Number, CEIC-1407).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Prior to starting the inclusion, all patients signed the informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}